DAX6.050-3,4%  Dow12.119-2,2%  Euro1,24320,6% 
ESt502.069-2,4%  Nas2.748-2,8%  Öl98,82-2,8% 
TDax730,9-2,7%  Nikkei8.440-1,2%  Gold1.6264,2% 
Kurse + Charts + RealtimeNews + AnalysenFundamentalUnternehmenzugeh. WertpapiereAktion
Kurs + ChartChart (groß)News + AdhocBilanz/GuVTermineZertifikateDepot
Times + SalesChart-AnalyseAnalysenDividende/HVProfilOptionsscheineWatchlist
BörsenplätzeChartvergleichKurszieleVergleichInsidertradesKnock-outsmyHome
OrderbuchRealtime StuttgartRSS FeedAnalyseim ForumFondsSenden/Drucken
HistorischRealtime PushmyNews neuAusblickIR-DatenAnleihen
handeln

11.02.2012 15:17

Senden

UBS Asks: Has Greece Already Been Printing 'Quasi-Drachmas'?!

UBS zu myNews hinzufügen Was ist das?

Quelle: Business Insider

In a note from this week, UBS economist Stephane Deo asks: Is Greece (already) printing its own money?  Deo centers on two areas: The first is the expanding balance sheet of the Greek central bank via the ELA (Emergency Liquidity Assistance) a scheme by which the national central banks help in keeping the domestic banking industry solvent.The other focus area is a little more intriguing and arcane. He asks specifically: Are quasi-drachmas being issued? Quasi-drachmas? Well what he's referring to is a scheme whereby the state has paid hospital suppliers in the form of domestically issued bonds:The Greek state hospitals accumulated arrears to suppliers during the period from 2005 to 2010. In May-June 2010, the Greek government decided to put an end to this practice and decided to take up this outstanding debt (law 3867/2010). In the following months, all the accumulated debt of public hospitals and the healthcare system from 2005 to mid 2007 was settled on a cash basis. The amount was EUR1.5bn for the years 2005 and 2006, with an additional EUR240 million for the first half of 2007. A total of EUR5.6bn accumulated between 2007 and 2010, was settled with zero coupon bonds. This was the creation of the “Pharma-Bonds”.  These financial instruments are bonds, and have all the characteristics of Hellenic Republic Bonds: they bear international securities identification numbers (ISINs); they are negotiable on the Athens Exchange and they rank pari passu with other Greek debt. The government, in one of its press releases, notes that “bondholders who choose to discount these bonds at the banks will crystallise a 19% discount versus their original claim.”We would argue, however, that they are more than just another bond issued by the Greek government. To be specific, they seem to us very akin to what economists call quasi-monies. These quasi-monies have appeared in a number of cases, usually put in place by government to find an escape valve out of nominal fiscal rigidities in the face of a financing issue. This especially happens in a case of a government of a monetary union that cannot print money to fund its deficit.Deo goes onto compare these "Pharma-Bonds" to the famous IOUs issued in California in 2009, when the state no longer had the cash to pay some employees and vendors. Argentina did something similar during its famous debt crisis -- creating quasi money vehicles when it could no longer literally create money.And in the case of Greece, the pharma-bonds seem unusually money-like, in that they can be deposited with a bank, which can them pledge them as collateral for real cash.He concludes:If a country issues a bond as repayment, even temporarily, for a supplier, then there is no withdrawal of money from the private sector as no-one purchases the bond with cash. It is a form of barter in which the vendor provides a good to the administration and receives a financial instrument created ex nihilo from the  same government. This is quite complex and tortuous, but at the end of the day it is not that far away from money printing in Greece.(Via @dutch_book)Please follow Money Game on Twitter and Facebook.Join the conversation about this story »See Also:IT'S OFFICIAL: GREEK AGREEMENT DONE, STATEMENT COMING SHORTLYLIVE: Violence Breaks Out In Greece, Police Union Threatens To Issue Warrants For EU/IMF OfficialsThere's A Whole Slew Of Ugly Headlines And Stories Out Of Greece Today

Weiter zum vollständigen Artikel bei "Business Insider"

Kommentare zu diesem Artikel

Geben Sie jetzt einen Kommentar zu diesem Artikel ab.
 Kommentar hinzufügen 
  • Relevant
  • Alle
  • vom Unternehmen
  • Sprache:
  • Alle
  • DE
  • EN
  • Sortieren:
  • Datum
  • meistgelesen
Keine Nachrichten im Zeitraum eines Monats in dieser Kategorie verfügbar
Um Ihnen die Übersicht über die große Anzahl an Nachrichten, die jeden Tag für ein Unternehmen erscheinen, etwas zu erleichtern, haben wir den Nachrichtenfeed in folgende Kategorien aufgeteilt:

Relevant: Nachrichten von ausgesuchten Quellen, die sich im Speziellen mit diesem Unternehmen befassen
Alle: Alle Nachrichten, die dieses Unternehmen betreffen. Z.B. auch Marktberichte die außerdem auch andere Unternehmen betreffen
vom Unternehmen: Nachrichten und Adhoc-Meldungen, die vom Unternehmen selbst veröffentlicht werden

UBS AG (N) zu myNews hinzufügen Was ist das?
  • Alle
  • Buy
  • Hold
  • Sell
11.05.12UBS buyVontobel Research
07.05.12UBS outperformRBC Capital Markets
04.05.12UBS buyNomura
03.05.12UBS holdDeutsche Bank AG
03.05.12UBS overweightMorgan Stanley
11.05.12UBS buyVontobel Research
07.05.12UBS outperformRBC Capital Markets
04.05.12UBS buyNomura
03.05.12UBS overweightMorgan Stanley
02.05.12UBS buyVontobel Research
03.05.12UBS holdDeutsche Bank AG
03.05.12UBS neutralBanc of America Securities-Merrill Lynch
03.05.12UBS holdSociété Générale Group S.A. (SG)
03.05.12UBS haltenIndependent Research GmbH
02.05.12UBS neutralCredit Suisse Group
03.05.12UBS underperformExane-BNP Paribas SA
10.04.12UBS underperformCheuvreux SA
30.03.12UBS underperformExane-BNP Paribas SA
08.03.12UBS underperformExane-BNP Paribas SA
14.02.12UBS underperformExane-BNP Paribas SA
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für UBS AG (N) nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen
Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"

AKTIEN IN DIESEM ARTIKEL

UBS AG (N)9,05
-1,19%
UBS Jahreschart

ANZEIGE

ANZEIGE

Was halten Sie von nutzergenerierten Chartanalysen auf finanzen.net?
Ich würde liebend gerne mein Wissen über Chartanalyse dem Publikum von finanzen.net zur Verfügung stellen.
Ich kenne mich bei Chartanalyse nicht so gut aus, halte nutzergenerierte Chartanalysen aber für einen echten Mehrwert.
Ich halte nichts von den Methoden der Chartanalyse und habe deshalb auch kein Interesse an nutzergenerierten Analysen.
 Abstimmen